Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01844687 · ClinicalTrials.gov registry record · Phase 2
Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana
A Phase 2 study of Smoking, Marijuana, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 3
- Study locations
NCT01844687 is a Phase 2 study of Smoking, Marijuana that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 50 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT01844687, a Phase 2 study of Smoking, Marijuana, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of this study is to assess the effects of oral cannabidiol (CBD; 0, 200, 400, 800 mg) on smoked marijuana's (0, 5.6% THC) subjective, reinforcing, cognitive, and cardiovascular effects. This experiment is expected to reveal CBD's intrinsic effects when combined with placebo marijuana, as well as its ability to modulate the behavioral effects of active marijuana.
Conditions Studied
Interventions
- DRUG CBD
Study Locations (3)
Kentucky
- University of Kentucky, Straus Behavioral Research Bldg., 515 Oldham Ct. - Lexington
New York
- Marijuana Outpatient Lab 1051 Riverside Dr. Unit #120 - New York
South Carolina
- Center for Drug and Alcohol Programs, Room 459 North, 67 President St. - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-05 |
| Est. Completion | 2014-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01844687
The ClinicalTrials.gov registry entry for NCT01844687 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking, Marijuana appearing as the primary indexed condition, and to 1 intervention - of which CBD is the first listed.
NCT01844687 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Kentucky, New York, South Carolina.
Frequently Asked Questions
What is clinical trial NCT01844687 about?
NCT01844687 is a clinical study titled "Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana". The objective of this study is to assess the effects of oral cannabidiol (CBD; 0, 200, 400, 800 mg) on smoked marijuana's (0, 5.6% THC) subjective, reinforcing, cognitive, and cardiovascular effects. This experiment is expected to reveal CBD's intrinsic effects when combined with placebo marijuana, ...
What is the current status of trial NCT01844687?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2013-05. Estimated completion is 2014-10.
What conditions does trial NCT01844687 study?
This clinical trial studies the following conditions: Smoking, Marijuana.
What interventions are being tested in trial NCT01844687?
The interventions under investigation include: CBD (DRUG).
Who is sponsoring clinical trial NCT01844687?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01844687 being conducted?
This trial has 3 study locations across Kentucky, New York, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.